619 research outputs found
A Spectrophotometric Study Of The Nitrogen(Doublet-D) And Nitrogen(Doublet-P) States In The Aurora
Thesis (M.S.) University of Alaska Fairbanks, 198
Dark Matter and Baryons in the Most X-ray Luminous and Merging Galaxy Cluster RX J1347.5-1145
The galaxy cluster RX J1347-1145 is one of the most X-ray luminous and most
massive clusters known. Its extreme mass makes it a prime target for studying
issues addressing cluster formation and cosmology. In this paper we present new
high-resolution HST/ACS and Chandra X-ray data. The high resolution and
sensitivity of ACS enabled us to detect and quantify several new multiply
imaged sources, we now use a total of eight for the strong lensing analysis.
Combining this information with shape measurements of weak lensing sources in
the central regions of the cluster, we derive a high-resolution,
absolutely-calibrated mass map. This map provides the best available
quantification of the total mass of the central part of the cluster to date. We
compare the reconstructed mass with that inferred from the new Chandra X-ray
data, and conclude that both mass estimates agree extremely well in the
observed region, namely within 400 / h_70 kpc of the cluster center. In
addition we study the major baryonic components (gas and stars) and hence
derive the dark matter distribution in the center of the cluster. We find that
the dark matter and baryons are both centered on the BCG within the
uncertainties (alignment is better than <10 kpc). We measure the corresponding
1-D profiles and find that dark matter distribution is consistent with both NFW
and cored profiles, indicating that a more extended radial analysis is needed
to pinpoint the concentration parameter, and hence the inner slope of the dark
matter profile.Comment: 12 pages, Accepted for publication in ApJ, full-res version
http://www.physics.ucsb.edu/~marusa/RXJ1347.pd
Direct Observation of Cosmic Strings via their Strong Gravitational Lensing Effect: II. Results from the HST/ACS Image Archive
We have searched 4.5 square degrees of archival HST/ACS images for cosmic
strings, identifying close pairs of similar, faint galaxies and selecting
groups whose alignment is consistent with gravitational lensing by a long,
straight string. We find no evidence for cosmic strings in five large-area HST
treasury surveys (covering a total of 2.22 square degrees), or in any of 346
multi-filter guest observer images (1.18 square degrees). Assuming that
simulations ccurately predict the number of cosmic strings in the universe,
this non-detection allows us to place upper limits on the unitless Universal
cosmic string tension of G mu/c^2 < 2.3 x 10^-6, and cosmic string density of
Omega_s < 2.1 x 10^-5 at the 95% confidence level (marginalising over the other
parameter in each case). We find four dubious cosmic string candidates in 318
single filter guest observer images (1.08 square degrees), which we are unable
to conclusively eliminate with existing data. The confirmation of any one of
these candidates as cosmic strings would imply G mu/c^2 ~ 10^-6 and Omega_s ~
10^-5. However, we estimate that there is at least a 92% chance that these
string candidates are random alignments of galaxies. If we assume that these
candidates are indeed false detections, our final limits on G mu/c^2 and
Omega_s fall to 6.5 x 10^-7 and 7.3 x 10^-6. Due to the extensive sky coverage
of the HST/ACS image archive, the above limits are universal. They are quite
sensitive to the number of fields being searched, and could be further reduced
by more than a factor of two using forthcoming HST data.Comment: 21 pages, 18 figure
Recommended from our members
Dark Matter and Baryons in the Most X-ray Luminous and Merging Galaxy Cluster RX
The Quiescent Intracluster Medium in the Core of the Perseus Cluster
Clusters of galaxies are the most massive gravitationally-bound objects in
the Universe and are still forming. They are thus important probes of
cosmological parameters and a host of astrophysical processes. Knowledge of the
dynamics of the pervasive hot gas, which dominates in mass over stars in a
cluster, is a crucial missing ingredient. It can enable new insights into
mechanical energy injection by the central supermassive black hole and the use
of hydrostatic equilibrium for the determination of cluster masses. X-rays from
the core of the Perseus cluster are emitted by the 50 million K diffuse hot
plasma filling its gravitational potential well. The Active Galactic Nucleus of
the central galaxy NGC1275 is pumping jetted energy into the surrounding
intracluster medium, creating buoyant bubbles filled with relativistic plasma.
These likely induce motions in the intracluster medium and heat the inner gas
preventing runaway radiative cooling; a process known as Active Galactic
Nucleus Feedback. Here we report on Hitomi X-ray observations of the Perseus
cluster core, which reveal a remarkably quiescent atmosphere where the gas has
a line-of-sight velocity dispersion of 164+/-10 km/s in a region 30-60 kpc from
the central nucleus. A gradient in the line-of-sight velocity of 150+/-70 km/s
is found across the 60 kpc image of the cluster core. Turbulent pressure
support in the gas is 4% or less of the thermodynamic pressure, with large
scale shear at most doubling that estimate. We infer that total cluster masses
determined from hydrostatic equilibrium in the central regions need little
correction for turbulent pressure.Comment: 31 pages, 11 Figs, published in Nature July
The Imaging X-ray Polarimetry Explorer (IXPE): Technical Overview
The Imaging X-ray Polarimetry Explorer (IXPE) will expand the information space for study of cosmic sources, by adding linear polarization to the properties (time, energy, and position) observed in x-ray astronomy. Selected in 2017 January as a NASA Astrophysics Small Explorer (SMEX) mission, IXPE will be launched into an equatorial orbit in 2021. The IXPE mission will provide scientifically meaningful measurements of the x-ray polarization of a few dozen sources in the 2-8 keV band, including polarization maps of several x-ray-bright extended sources and phase-resolved polarimetry of many bright pulsating x-ray sources
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.
Telomere length is a risk factor in disease and the dynamics of telomere length are crucial to our understanding of cell replication and vitality. The proliferation of whole genome sequencing represents an unprecedented opportunity to glean new insights into telomere biology on a previously unimaginable scale. To this end, a number of approaches for estimating telomere length from whole-genome sequencing data have been proposed. Here we present Telomerecat, a novel approach to the estimation of telomere length. Previous methods have been dependent on the number of telomeres present in a cell being known, which may be problematic when analysing aneuploid cancer data and non-human samples. Telomerecat is designed to be agnostic to the number of telomeres present, making it suited for the purpose of estimating telomere length in cancer studies. Telomerecat also accounts for interstitial telomeric reads and presents a novel approach to dealing with sequencing errors. We show that Telomerecat performs well at telomere length estimation when compared to leading experimental and computational methods. Furthermore, we show that it detects expected patterns in longitudinal data, repeated measurements, and cross-species comparisons. We also apply the method to a cancer cell data, uncovering an interesting relationship with the underlying telomerase genotype
Hitomi (ASTRO-H) X-ray Astronomy Satellite
The Hitomi (ASTRO-H) mission is the sixth Japanese x-ray astronomy satellite developed by a large international collaboration, including Japan, USA, Canada, and Europe. The mission aimed to provide the highest energy resolution ever achieved at E > 2 keV, using a microcalorimeter instrument, and to cover a wide energy range spanning four decades in energy from soft x-rays to gamma rays. After a successful launch on February 17, 2016, the spacecraft lost its function on March 26, 2016, but the commissioning phase for about a month provided valuable information on the onboard instruments and the spacecraft system, including astrophysical results obtained from first light observations. The paper describes the Hitomi (ASTRO-H) mission, its capabilities, the initial operation, and the instruments/spacecraft performances confirmed during the commissioning operations for about a month
Recommended from our members
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707
- …